Retinow develops digital health solutions, likely medical devices or software, for use in healthcare settings. They aim to improve patient care through technological advancements in the medical field.
Funding
$100.4K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Millions worldwide suffer from eye diseases like diabetic retinopathy, macular degeneration, and glaucoma, which can lead to vision loss if not detected and treated early. Traditional eye exams often require expensive equipment and specialist access, leaving many at risk of delayed diagnosis and potential blindness.
Solution
Retinow develops a portable, AI-powered fundus camera designed for early detection of vision-threatening diseases. The device enables rapid retinal imaging in primary care settings, eliminating the need for a specialist during initial screening. Retinow's AI algorithms analyze the images to identify indicators of diabetic retinopathy and other conditions, providing a decision-support mechanism for healthcare providers. By facilitating early diagnosis and referral, Retinow aims to reduce the global burden of preventable vision loss.
Target Audience
The primary target audience includes primary care physicians, optometrists, and healthcare providers in underserved communities who need a cost-effective and accessible solution for early detection of eye diseases.
Features
- Portable fundus camera for easy retinal imaging in various clinical settings
- AI-powered image analysis for automated detection of diabetic retinopathy, macular degeneration, and glaucoma
- Decision-support system providing rapid screening results without requiring a specialist
- Cloud connectivity for secure data storage and remote access to reports
- Integration with existing healthcare workflows through standard APIs